Leonardo Roever | Research & Reviews | University of Ub

Recommended Conferences

Leonardo Roever

Leonardo Roever

Leonardo Roever
Principal Investigator
Department of Clinical Research
Av. Pará, 1720 - Bairro Umuarama.
Uberlândia - MG - CEP 38400-902,
Brazil,
leonardoroever@hotmail.com

 
 

Biography

Dr. Leonardo Roever was graduated in 2002, had his specialization in Unifesp (2003), Masters degree in Health Sciences from the UFU (2008). Editor in Chief - Evidence Based Medicine and Practice and Quality in Primary Care. Academic Editor of Medicine (USA - Baltimore, Maryland - Impact Factor - 2.133). Editor-in-Chief of Research Topics: Cardiac Remodeling: New Insights in Physiological and Pathological Adaptations of Frontiers in Physiology (Impact Factor - 4.031) in Switzerland, Special issue entitled: Coronary Artery Disease (Journal of Cardiovascular Diseases & Diagnosis). Executive Editor of Atherosclerosis: Open Access. Editorial board member of the Journal of Epidemiology, Internal Medicine, Translational Medicine, Cardiovascular Diseases & Diagnosis, Emergency Medicine and others. Reviewer journals such as British Medical Journal (BMJ), Circulation, European Heart Journal, JACC, JAMA Internal Medicine, Stem Cells, Nature (EJCN), Stroke, Neurology, Chest, Critical Care Medicine, Circulation: Heart Failure‏, JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, JAHA, The American Journal of Medicine, The American Journal of Sports Medicine and others. Ad Hoc is the American Heart Association (AHA-USA) and the National Institute of Health (NIH-USA). The total of publications comprises 97 articles in journals specialized as an author and/or co-authored, 19 abstracts in conference proceedings, and 2 international book chapter.

 

Research Interest

Atherosclerosis, ectopic adiposopathy, biomarkers, inflammatory markers, metabolic syndrome, coronary artery disease, cardiovascular prevention, heart failure, hypertension, arrhythmia, aging and development of new diagnostic and therapeutic methods.